LH Laboratory Corporation of America Holdings

Price (delayed)

$207.49

Market cap

$20.21B

P/E Ratio

55.93

Dividend/share

N/A

EPS

$3.71

Enterprise value

$26.77B

Sector: Healthcare
Industry: Diagnostics & Research
Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Highlights

The debt has declined by 5% year-on-year
The company's equity rose by 4.7% QoQ and by 2.9% YoY
LH's net income has plunged by 58% YoY but it is up by 13% from the previous quarter
Laboratory Corp Of America Holdings's EPS has shrunk by 57% YoY but it has increased by 13% QoQ
The price to earnings (P/E) is 163% higher than the 5-year quarterly average of 21.3 and 78% higher than the last 4 quarters average of 31.4
The gross margin has contracted by 3.2% YoY

Key stats

What are the main financial stats of LH
Market
Shares outstanding
97.4M
Market cap
$20.21B
Enterprise value
$26.77B
Valuations
Price to earnings (P/E)
55.93
Price to book (P/B)
2.74
Price to sales (P/S)
1.76
EV/EBIT
31.81
EV/EBITDA
16.38
EV/Sales
2.33
Earnings
Revenue
$11.47B
EBIT
$841.4M
EBITDA
$1.63B
Free cash flow
$1.17B
Per share
EPS
$3.71
Free cash flow per share
$12.08
Book value per share
$75.65
Revenue per share
$118.05
TBVPS
$67.38
Balance sheet
Total assets
$17.85B
Total liabilities
$10.48B
Debt
$7.11B
Equity
$7.35B
Working capital
$378.8M
Liquidity
Debt to equity
0.97
Current ratio
1.12
Quick ratio
0.91
Net debt/EBITDA
4.01
Margins
EBITDA margin
14.2%
Gross margin
27.2%
Net margin
3.2%
Operating margin
6.8%
Efficiency
Return on assets
2%
Return on equity
5%
Return on invested capital
8.2%
Return on capital employed
5.7%
Return on sales
7.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$11.47B
Gross profit
$3.13B
Operating income
$781.4M
Net income
$362.2M
Gross margin
27.2%
Net margin
3.2%
The net margin has dropped by 58% year-on-year but it has increased by 14% since the previous quarter
LH's net income has plunged by 58% YoY but it is up by 13% from the previous quarter
The operating margin has contracted by 41% YoY and by 4.2% from the previous quarter
Laboratory Corp Of America Holdings's operating income has decreased by 40% YoY and by 4.6% QoQ

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
P/E
55.93
P/B
2.74
P/S
1.76
EV/EBIT
31.81
EV/EBITDA
16.38
EV/Sales
2.33
The price to earnings (P/E) is 163% higher than the 5-year quarterly average of 21.3 and 78% higher than the last 4 quarters average of 31.4
Laboratory Corp Of America Holdings's EPS has shrunk by 57% YoY but it has increased by 13% QoQ
The P/B is 30% higher than the last 4 quarters average of 2.1 and 19% higher than the 5-year quarterly average of 2.3
The company's equity rose by 4.7% QoQ and by 2.9% YoY
LH's price to sales (P/S) is 35% higher than its last 4 quarters average of 1.3 and 26% higher than its 5-year quarterly average of 1.4

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA has shrunk by 60% YoY but it is up by 11% QoQ
LH's ROE has shrunk by 58% YoY but it is up by 14% QoQ
The company's return on invested capital fell by 47% YoY but it rose by 3.8% QoQ
Laboratory Corp Of America Holdings's return on sales has decreased by 44% YoY but it has increased by 2.8% QoQ

Dividends

What is LH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LH.

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 70% greater than its total liabilities
The quick ratio has contracted by 2.2% from the previous quarter and by 2.2% YoY
The debt is 3.2% smaller than the equity
LH's debt to equity is down by 8% year-on-year and by 4% since the previous quarter
The company's equity rose by 4.7% QoQ and by 2.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.